Takahashi H - Search Results

1

Plasma amino acid concentration in patients with IgG4-related disease.

Nakamura H, Kanda M, Amaike H, Nagahata K, Takahashi H. Nakamura H, et al. Among authors: takahashi h. Clin Exp Rheumatol. 2024 Apr 5. doi: 10.55563/clinexprheumatol/std9t8. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 38607674 No abstract available.

2

Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody-Associated Dermatomyositis.

Nagahata K, Sugawara M, Kanda M, Takahashi H. Nagahata K, et al. Among authors: takahashi h. J Rheumatol. 2023 Jun;50(6):846. doi: 10.3899/jrheum.220649. Epub 2022 Dec 1. J Rheumatol. 2023. PMID: 36455950 No abstract available.

3

IgG4-related disease in the Japanese population: a genome-wide association study.

Terao C, Ota M, Iwasaki T, Shiokawa M, Kawaguchi S, Kuriyama K, Kawaguchi T, Kodama Y, Yamaguchi I, Uchida K, Higasa K, Yamamoto M, Kubota K, Yazumi S, Hirano K, Masaki Y, Maguchi H, Origuchi T, Matsui S, Nakazawa T, Shiomi H, Kamisawa T, Hasebe O, Iwasaki E, Inui K, Tanaka Y, Ohshima KI, Akamizu T, Nakamura S, Nakamura S, Saeki T, Umehara H, Shimosegawa T, Mizuno N, Kawano M, Azumi A, Takahashi H, Mimori T, Kamatani Y, Okazaki K, Chiba T, Kawa S, Matsuda F; Japanese IgG4-Related Disease Working Consortium. Terao C, et al. Among authors: takahashi h. Lancet Rheumatol. 2019 Sep;1(1):e14-e22. doi: 10.1016/S2665-9913(19)30006-2. Epub 2019 Aug 6. Lancet Rheumatol. 2019. PMID: 38229354

4

Safety and efficacy of various dosages of ocrelizumab in Japanese patients with rheumatoid arthritis with an inadequate response to methotrexate therapy: a placebo-controlled double-blind parallel-group study.

Harigai M, Tanaka Y, Maisawa S; JA21963 Study Group. Harigai M, et al. J Rheumatol. 2012 Mar;39(3):486-95. doi: 10.3899/jrheum.110994. Epub 2012 Jan 15. J Rheumatol. 2012. PMID: 22247354 Free article. Clinical Trial.

5

Socio-economic association of alcohol use disorder and cardiovascular and alcohol-associated liver disease from 2010 to 2019.

Danpanichkul P, Chen VL, Chaiyakunapruk N, Auttapracha T, Kongarin S, Ng CH, Duangsonk K, Muthiah MD, Sukphutanan B, Sim B, Huang DQ, Seko Y, Lee BP, Takahashi H, Noureddin M, Lazarus JV, Díaz LA, Arab JP, Mellinger JL, Liangpunsakul S, Wijarnpreecha K. Danpanichkul P, et al. Among authors: takahashi h. Aliment Pharmacol Ther. 2024 May 29. doi: 10.1111/apt.18095. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38808961

6

Safety and efficacy of bronchial thermoplasty in refractory asthma with severe obstructive respiratory dysfunction.

Inoue T, Isogai S, Yamamoto N, Hiramatsu N, Niwa Y, Takahashi H, Kimura Y, Horiguchi T, Goto Y, Hashimoto N, Imaizumi K. Inoue T, et al. Among authors: takahashi h. Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241254980. doi: 10.1177/17534666241254980. Ther Adv Respir Dis. 2024. PMID: 38804685 Free article.

7

Significant role of 1,25-dihydroxyvitamin D on serum calcium levels after total thyroidectomy: a prospective cohort study.

Yamashita H, Mori Y, Sato S, Shindo H, Yoshimoto K, Tachibana S, Fukuda T, Takahashi H. Yamashita H, et al. Among authors: takahashi h. Front Endocrinol (Lausanne). 2024 May 13;15:1360464. doi: 10.3389/fendo.2024.1360464. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38803480 Free PMC article.

8

The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma.

Ito Y, Yamada D, Kobayashi S, Sasaki K, Iwagami Y, Tomimaru Y, Asaoka T, Noda T, Takahashi H, Shimizu J, Doki Y, Eguchi H. Ito Y, et al. Among authors: takahashi h. Cancer Lett. 2024 May 25:216997. doi: 10.1016/j.canlet.2024.216997. Online ahead of print. Cancer Lett. 2024. PMID: 38801887

9

Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT.

Abe M, Okubo Y, Takahashi H, Endo K, Chaudhari S, Deignan C, Amouzadeh H, Hino R. Abe M, et al. Among authors: takahashi h. Dermatol Ther (Heidelb). 2024 May 27. doi: 10.1007/s13555-024-01179-z. Online ahead of print. Dermatol Ther (Heidelb). 2024. PMID: 38801606

10

Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations.

Hara N, Hiraoka A, Nakai M, Shiraki M, Namisaki T, Miyaaki H, Hisanaga T, Takahashi H, Ohama H, Tada F, Sakamoto N, Nakao K, Takami T, Eguchi Y, Yoshiji H. Hara N, et al. Among authors: takahashi h. Hepatol Res. 2024 May 27. doi: 10.1111/hepr.14060. Online ahead of print. Hepatol Res. 2024. PMID: 38801372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,188 results

Search Page